Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer
出版年份 2011 全文链接
标题
Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer
作者
关键词
-
出版物
CANCER
Volume 117, Issue 17, Pages 3889-3899
出版商
Wiley
发表日期
2011-02-26
DOI
10.1002/cncr.25935
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small cell lung cancer (NSCLC): A randomized, double-blind phase III trial (ZODIAC)
- (2017) R. S. Herbst et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib treatment efficacy and KRAS biomarker status in the Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial.
- (2017) R. S. Herbst et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating vascular endothelial growth factor (VEGF) as a biomarker for bevacizumab-based therapy in metastatic colorectal, non-small cell lung, and renal cell cancers: Analysis of phase III studies.
- (2017) C. Bernaards et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib versus placebo in patients with advanced non-small cell lung cancer (NSCLC) after prior therapy with an EGFR tyrosine kinase inhibitor (TKI): A randomized, double-blind phase III trial (ZEPHYR).
- (2017) J. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of germline polymorphisms in VEGF to predict tumor response and progression-free survival in non-small cell lung cancer (NSCLC) patients treated with sorafenib: Subset pharmacogenetic analysis of Eastern Cooperative Oncology Group (ECOG) trial E2501.
- (2017) W. Zhang et al. JOURNAL OF CLINICAL ONCOLOGY
- Plasma Cytokine and Angiogenic Factor Profiling Identifies Markers Associated with Tumor Shrinkage in Early-Stage Non-Small Cell Lung Cancer Patients Treated with Pazopanib
- (2010) P. G. Nikolinakos et al. CANCER RESEARCH
- Soluble Adhesion Molecules E-Cadherin, Intercellular Adhesion Molecule-1, and E-Selectin as Lung Cancer Biomarkers
- (2010) Athena Gogali et al. CHEST
- Angiogenesis in Non-small Cell Lung Cancer
- (2010) Quan Sing Ng et al. JOURNAL OF THORACIC IMAGING
- Angiogenic Markers Show High Prognostic Impact on Survival in Marginally Operable Non-small Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy
- (2010) Sigve Andersen et al. Journal of Thoracic Oncology
- Protease-activated receptors, cyclo-oxygenases and pro-angiogenic signalling in endothelial cells
- (2009) Caroline P.D. Wheeler-Jones et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
- (2009) Yongping Crawford et al. CANCER CELL
- Evaluation of MicroRNA Expression Profiles That May Predict Recurrence of Localized Stage I Non-Small Cell Lung Cancer after Surgical Resection
- (2009) S. K. Patnaik et al. CANCER RESEARCH
- MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer
- (2009) M. Raponi et al. CANCER RESEARCH
- Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non-Small Cell Lung Cancer
- (2009) E. O. Hanrahan et al. CLINICAL CANCER RESEARCH
- The Role of Fibroblast Growth Factors in Tumor Growth
- (2009) M. Korc et al. CURRENT CANCER DRUG TARGETS
- MicroRNAs and Lung Cancer: New Oncogenes and Tumor Suppressors, New Prognostic Factors and Potential Therapeutic Targets
- (2009) Cecile Ortholan et al. CURRENT MEDICINAL CHEMISTRY
- VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
- (2009) Marja Lohela et al. CURRENT OPINION IN CELL BIOLOGY
- Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment
- (2009) M. Kreuter et al. EUROPEAN RESPIRATORY JOURNAL
- Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study
- (2009) Ronald B. Natale et al. JOURNAL OF CLINICAL ONCOLOGY
- Distinct Patterns of Cytokine and Angiogenic Factor Modulation and Markers of Benefit for Vandetanib and/or Chemotherapy in Patients With Non–Small-Cell Lung Cancer
- (2009) Emer O. Hanrahan et al. JOURNAL OF CLINICAL ONCOLOGY
- Protumor vs Antitumor Functions of IL-17
- (2009) G. Murugaiyan et al. JOURNAL OF IMMUNOLOGY
- Prognostic Impact of Fibroblast Growth Factor 2 in Non-small Cell Lung Cancer: Coexpression with VEGFR-3 and PDGF-B Predicts Poor Survival
- (2009) Tom Donnem et al. Journal of Thoracic Oncology
- Molecular Analysis-Based Treatment Strategies for the Management of Non-small Cell Lung Cancer
- (2009) Howard West et al. Journal of Thoracic Oncology
- Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: Relation to prognosis
- (2009) Barbara Bonnesen et al. LUNG CANCER
- Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: Correlations with patient survival and pleural effusion control
- (2009) I-Lin Hsu et al. LUNG CANCER
- Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients
- (2009) Xi Chen et al. LUNG CANCER
- The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors
- (2009) L. Jain et al. MOLECULAR CANCER THERAPEUTICS
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future Directions
- (2009) A. Morabito et al. ONCOLOGIST
- MicroRNAs: Opening a New Vein in Angiogenesis Research
- (2009) J. E. Fish et al. Science Signaling
- Circulating and imaging markers for angiogenesis
- (2008) Arvind P. Pathak et al. ANGIOGENESIS
- PDGF-BB is a Novel Prognostic Factor in Colorectal Cancer
- (2008) Yoshito Nakamura et al. ANNALS OF SURGICAL ONCOLOGY
- Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
- (2008) Tadahiko Kubo et al. CANCER
- MicroRNA Signature Predicts Survival and Relapse in Lung Cancer
- (2008) Sung-Liang Yu et al. CANCER CELL
- Serum Insulin-Like Growth Factor-I and Platelet-Derived Growth Factor as Biomarkers of Breast Cancer Prognosis
- (2008) P. Pasanisi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non-Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab--an Eastern Cooperative Oncology Group Study
- (2008) A. Dowlati et al. CLINICAL CANCER RESEARCH
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients
- (2008) Kyuichi Kadota et al. EUROPEAN JOURNAL OF CANCER
- Prognostic versus predictive value of biomarkers in oncology
- (2008) C.N.A.M. Oldenhuis et al. EUROPEAN JOURNAL OF CANCER
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- Reproducibility of Tumor Perfusion Measurements Using 15O-Labeled Water and PET
- (2008) A. J. de Langen et al. JOURNAL OF NUCLEAR MEDICINE
- Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells
- (2008) Tom Donnem et al. Journal of Thoracic Oncology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started